AETIOPATHOGENESIS OF MUTRAVAHA SROTODUSHTI W.S.R. TO U.T.I. AND EFFECT OF CHANDRAPRABHAVATI

Abstract

Urinary tract infection is potentially a serious condition and failure to realize this may lead to development of serious chronic pyelonephritis and chronic renal failure. If we look at the symptomatology of Mutravaha Srotodushti, it appears that various stages of acute and chronic urinary tract infections have been covered under this heading including the inflammatory conditions with irritation during micturition. With the introduction of effective antibiotics problem has been solved to some extent but the use of antibiotics have its own limitations, side effects and recurrence. Simultaneously, increasing incidence of resistance and high cost of therapy are common problems. Keeping these facts in mind this study was planned. This clinical study was prospective and unicentral work designed to assess the efficacy of Chandrapraba Vati in the management of Mutravaha Srotodushti. It was carried out in single group with a sample size of 30 patients. Ethical clearance from IEC was obtained. In this randomized clinical trial, patients with age ranged from 15-70 years of either sex were selected strictly following the inclusion and exclusion criteria. The trial drug was prepared and administered as per the textual guidelines. Standard criterias was set for evaluation. Analysis revealed statistically highly significant results on most of the variables of assessment criteria. 48.27% patients were markedly improved and 48.27% were moderately improved. Percentage relief in Dysuria was 82.75%. It reveals that Chandrapraba Vati has a tremendous role in the management of Mutravaha Srotodushti.